Why Teladoc Health, Inc.’s (TDOC) Stock Is Up 30.45%
As of Thursday, October 29, Teladoc Health, Inc.’s TDOC share price has surged by 30.45%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Technology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Rosalio Madrigal
Michael Rose
Michael Rose
Tudor Pop
| Share Statistics | TDOC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,551.3 | $196.1 | 51% |
|
| Shares Out (Mil) | 181.0 | 45.1 | 74% |
|
| Institutional Ownership | 99.2% | 79.3% | 86% |
|
| Float (Mil) | 180.4 | 40.0 | 72% |
|
| Beta | 2.14 | 1.12 | 93% |
|
| Avg Daily Volume (000s) | 5,953 | 214 | 93% |
|
| Price Change (52-week) |
3.4% | 49.6% | 54% |
|
| Growth | TDOC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 18.3% | 13.5% | 79% |
|
| Net Income (5yr) | 16.2% | 5.4% | 66% |
|
| EPS (5yr) | 26.7% | 15.5% | 78 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (26.3%) | (15.5%) | 24% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 2 | 3 | |
| Current EPS | ($0.190) | ($0.510) | ($0.597) | |
| Month Ago EPS | ($0.115) | ($0.783) | ($0.785) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.070) | ($0.737) | ($0.615) | |
| Year/Year Chg | (11.6%) | (55.1%) | (40.6%) | |
| Financials | TDOC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,490 | $192 | 63% |
|
| Net Income (TTM) (Mil) | ($177) | ($9) | 7% |
|
| EPS (TTM) | ($0.992) | ($1.000) | 21% |
|
| Operating Cash Flow (TTM) (Mil) | $261 | ($1) | 62% |
|
| Net Cash Flow (TTM) (Mil) | $95 | $2 | 76% |
|
| Long-Term Debt (Q1) (Mil) | $30 | $16 | 35% |
|
| Enterprise Value (Q1) (Mil) | $1,793 | $180 | 48% |
|
| Valuation | TDOC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.18 | 1.26 | 32% |
|
| P/E | na | 43.3 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.8 | na |
|
| Ratios | TDOC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 68.6% | 61.1% | 80% |
|
| Net Margin | (6.3%) | (24.1%) | 24% |
|
| ROA | (6.3%) | (22.3%) | 28% |
|
| ROE | (13.0%) | (6.7%) | 26% |
|
| Liabilities to Assets | 52.5% | 32.7% | 45% |
|
| F-Score | 5 | 4 | 50% |
|
Teladoc Health, Inc. did not pass any screens on 10/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors